Gefitinib in Treating Patients With Cervical Cancer

NCT00049556 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Cervical Cancer
Fallopian Tube Cancer
Ovarian Cancer
Primary Peritoneal Cavity Cancer

Interventions

DRUG: gefitinib
OTHER: immunohistochemistry staining method
OTHER: surface-enhanced laser desorption/ionization-time of flight mass spectrometry
PROCEDURE: biopsy
PROCEDURE: sentinel lymph node biopsy

Sponsor

National Cancer Institute (NCI)